Your browser doesn't support javascript.
loading
Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
Hoffmann, Katrin; Ganten, Tom; Gotthardtp, Daniel; Radeleff, Boris; Settmacher, Utz; Kollmar, Otto; Nadalin, Silvio; Karapanagiotou-Schenkel, Irini; von Kalle, Christof; Jäger, Dirk; Büchler, Markus W; Schemmer, Peter.
Afiliação
  • Hoffmann K; Department of General-, Visceral- and Transplantation-Surgery, Ruprecht-Karls-University, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. katrin.hoffmann@med.uni-heidelberg.de.
  • Ganten T; Department of Internal Medicine, Ruprecht-Karls-University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. tom.ganten@med.uni-heidelberg.de.
  • Gotthardtp D; Department of Internal Medicine, Ruprecht-Karls-University, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. daniel.gotthardt@med.uni-heidelberg.de.
  • Radeleff B; Department of Radiology, Ruprecht-Karls-University, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. boris.radeleff@med.uni-heidelberg.de.
  • Settmacher U; Department of General-, Visceral- and Vascular-Surgery, University Hospital, Erlanger Allee 101, 07747, Jena, Germany. avg@med.uni-jena.de.
  • Kollmar O; Department of General and Visceral Surgery, Georg-August-University, Robert-Koch-Str. 40, 37075, Göttingen, Germany. otto.kollmar@med.uni-goettingen.de.
  • Nadalin S; Department of Surgery, University Hospital, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany. silvio.nadalin@med.uni-tuebingen.de.
  • Karapanagiotou-Schenkel I; National Centre of Tumour Diseases, Ruprecht-Karls-University, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. irini.schenkel@nct-heidelberg.de.
  • von Kalle C; National Centre of Tumour Diseases, Ruprecht-Karls-University, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. christof.kalle@nct-heidelberg.de.
  • Jäger D; National Centre of Tumour Diseases, Ruprecht-Karls-University, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. dirk.jaeger@nct-heidelberg.de.
  • Büchler MW; Department of General-, Visceral- and Transplantation-Surgery, Ruprecht-Karls-University, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. markus.buechler@med.uni-heidelberg.de.
  • Schemmer P; Department of General-, Visceral- and Transplantation-Surgery, Ruprecht-Karls-University, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. peter.schemmer@med.uni-heidelberg.de.
BMC Cancer ; 15: 392, 2015 May 11.
Article em En | MEDLINE | ID: mdl-25957784
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Transplante de Fígado / Niacinamida / Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Transplante de Fígado / Niacinamida / Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha